Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma
- PMID: 8841504
Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma
Abstract
In the present work we studied the levels of activities of dipeptidyl-peptidase I (or cathepsin C, DPP-I) and dipeptidyl-peptidase II (DPP-II) and examined their isoelectric focusing profiles in matched pairs of human squamous cell lung carcinoma (SQCLC) and the lung from surgically treated patients (n = 33). The mean specific activities of DPP-I and DPP-II were higher in SQCLC (Stages I and II) than in the lung, but only the activity of DPP-II in Stage I SQCLC was significantly higher compared to the lung. The activities of both enzymes were higher in the tumor than in the lung in 10 of 20 Stage I SQCLC patients, but only in 3 of 13 Stage II SQCLC patients. The specific activities of DPP-I and DPP-II in the lungs showed a good correlation while the correlation of both enzyme activities in SQCLCs was poor. We observed only a small and mutually comparable activation of DPP-I in extracts from SQCLCs and from the lungs by dithiothreitol. The isoelectric focusing profile of several DPP-II forms in SQCLCs and the lungs was similar and the single major DPP-II isoform revealed in the tumors and lungs showed a pIapp of 5.3-5.2. The isoelectric focusing profile of DPP-I showed multiple enzyme forms in SQCLCs (pIapp 6.3-4.5) as well as in the lungs (pIapp 6.4-4.8). In SQCLCs, as well as in the lungs, the activities of the DPP-I forms with pIapp values < or = 5.6 were shifted by neuraminidase treatment to the site of the major DPP-I isoform with pIapp of about 6.0 and the zymograms then showed an another DPP-I with pIapp of 5.7, which was less discernible in the lung. In some patients, the DPP-I forms with pIapp values < or = 5.6 from SQCLC retained a greater percentage of activity distribution than did the DPP-I pIapp-counterparts from the lung.
Similar articles
-
Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.Neoplasma. 1997;44(4):219-39. Neoplasma. 1997. PMID: 9473776
-
Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.Neoplasma. 1998;45(5):318-31. Neoplasma. 1998. PMID: 9921922
-
Multiple forms of cathepsin B in human lung cancer.Int J Cancer. 1995 Mar 29;61(1):44-53. doi: 10.1002/ijc.2910610109. Int J Cancer. 1995. PMID: 7705933
-
[Morphologic and molecular-genetic characteristics of keratinization and apoptosis in squamous cell lung carcinoma].Arkh Patol. 2000 May-Jun;62(3):16-20. Arkh Patol. 2000. PMID: 10897431 Review. Russian.
-
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.Clin Sci (Lond). 2009 Sep 28;118(1):31-41. doi: 10.1042/CS20090047. Clin Sci (Lond). 2009. PMID: 19780719 Review.
Cited by
-
On the origin of serum CD26 and its altered concentration in cancer patients.Cancer Immunol Immunother. 2009 Nov;58(11):1723-47. doi: 10.1007/s00262-009-0728-1. Epub 2009 Jun 26. Cancer Immunol Immunother. 2009. PMID: 19557413 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical